Literature DB >> 2304903

Use of nonradioactive 2-deoxyglucose to study compartmentation of brain glucose metabolism and rapid regional changes in rate.

D B McDougal1, J A Ferrendelli, V Yip, M E Pusateri, J G Carter, M M Chi, B Norris, J Manchester, O H Lowry.   

Abstract

A method is presented for measuring rapid changes in the rate of glucose phosphorylation in mouse brain with nonradioactive 2-deoxyglucose (DG). After times as short as 1 min after DG injection, the mouse is frozen rapidly, and selected brain regions are analyzed enzymatically for DG, 2-deoxyglucose 6-phosphate (DG6P), and glucose. The rate of glucose phosphorylation can be directly calculated from the rate of change in DG6P, the average levels of DG and glucose, and a constant derived from direct comparison of the rate of changes in glucose and DG6P after decapitation. Experiments with large brain samples provided evidence for a 2% per min loss of DG6P and at least two compartments differing in their rates of glucose metabolism, one rapidly entered by DG with glucose phosphorylation almost double that of average brain and another more slowly entered with a much lower phosphorylation rate. The method is illustrated by changes in phosphorylation within 2 min after injection of a convulsant or an anesthetic and over a 48-min time course with and without anesthesia. The sensitivity of the analytical methods can be amplified as much as desired by enzymatic cycling. Consequently, the method is applicable to very small brain samples. Examples are given for regions with volumes of 5 x 10(-4) microliters, but studies with samples as small as single large cell bodies are feasible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304903      PMCID: PMC53474          DOI: 10.1073/pnas.87.4.1357

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  THE GLUCOSE CONTENT OF BRAIN IN ANAESTHESIA.

Authors:  C I MAYMAN; P D GATFIELD; B M BRECKENRIDGE
Journal:  J Neurochem       Date:  1964-06       Impact factor: 5.372

2.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

3.  Measurement of 2-deoxyglucose and 2-deoxyglucose 6-phosphate in tissues.

Authors:  J K Manchester; M M Chi; J G Carter; M E Pusateri; D B McDougal; O H Lowry
Journal:  Anal Biochem       Date:  1990-02-15       Impact factor: 3.365

4.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

5.  Measurement of regional brain glucose utilization in vivo using [2(-14)C] glucose.

Authors:  R Hawkins; W K Hass; J Ransohoff
Journal:  Stroke       Date:  1979 Nov-Dec       Impact factor: 7.914

6.  Invalidity of criticisms of the deoxyglucose method based on alleged glucose-6-phosphatase activity in brain.

Authors:  T Nelson; G Lucignani; J Goochee; A M Crane; L Sokoloff
Journal:  J Neurochem       Date:  1986-03       Impact factor: 5.372

7.  Enzymatic assays for 2-deoxyglucose and 2-deoxyglucose 6-phosphate.

Authors:  M M Chi; M E Pusateri; J G Carter; B J Norris; D B McDougal; O H Lowry
Journal:  Anal Biochem       Date:  1987-03       Impact factor: 3.365

8.  A method for the simultaneous estimation of regional rates of glucose influx and phosphorylation in rat brain using radiolabeled 2-deoxyglucose.

Authors:  V J Cunningham; J E Cremer
Journal:  Brain Res       Date:  1981-09-28       Impact factor: 3.252

9.  Metabolic fluxes between [14C]2-deoxy-D-glucose and [14C]2-deoxy-D-glucose-6-phosphate in brain in vivo.

Authors:  M T Huang; R L Veech
Journal:  J Neurochem       Date:  1985-02       Impact factor: 5.372

  9 in total
  7 in total

1.  In vivo opening of the mitochondrial permeability transition pore in a rat model of ventricular fibrillation and closed-chest resuscitation.

Authors:  Iyad M Ayoub; Jeejabai Radhakrishnan; Raúl J Gazmuri
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 2.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

3.  Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI.

Authors:  Fatima A Nasrallah; Guilhem Pagès; Philip W Kuchel; Xavier Golay; Kai-Hsiang Chuang
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-15       Impact factor: 6.200

Review 4.  Alzheimer's disease: A matter of blood-brain barrier dysfunction?

Authors:  Axel Montagne; Zhen Zhao; Berislav V Zlokovic
Journal:  J Exp Med       Date:  2017-10-23       Impact factor: 14.307

5.  FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study.

Authors:  Ya-Nan Ou; Wei Xu; Jie-Qiong Li; Yu Guo; Mei Cui; Ke-Liang Chen; Yu-Yuan Huang; Qiang Dong; Lan Tan; Jin-Tai Yu
Journal:  Alzheimers Res Ther       Date:  2019-06-29       Impact factor: 6.982

6.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Authors:  Melanie D Sweeney; Axel Montagne; Abhay P Sagare; Daniel A Nation; Lon S Schneider; Helena C Chui; Michael G Harrington; Judy Pa; Meng Law; Danny J J Wang; Russell E Jacobs; Fergus N Doubal; Joel Ramirez; Sandra E Black; Maiken Nedergaard; Helene Benveniste; Martin Dichgans; Costantino Iadecola; Seth Love; Philip M Bath; Hugh S Markus; Rustam Al-Shahi Salman; Stuart M Allan; Terence J Quinn; Rajesh N Kalaria; David J Werring; Roxana O Carare; Rhian M Touyz; Steve C R Williams; Michael A Moskowitz; Zvonimir S Katusic; Sarah E Lutz; Orly Lazarov; Richard D Minshall; Jalees Rehman; Thomas P Davis; Cheryl L Wellington; Hector M González; Chun Yuan; Samuel N Lockhart; Timothy M Hughes; Christopher L H Chen; Perminder Sachdev; John T O'Brien; Ingmar Skoog; Leonardo Pantoni; Deborah R Gustafson; Geert Jan Biessels; Anders Wallin; Eric E Smith; Vincent Mok; Adrian Wong; Peter Passmore; Frederick Barkof; Majon Muller; Monique M B Breteler; Gustavo C Román; Edith Hamel; Sudha Seshadri; Rebecca F Gottesman; Mark A van Buchem; Zoe Arvanitakis; Julie A Schneider; Lester R Drewes; Vladimir Hachinski; Caleb E Finch; Arthur W Toga; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Alzheimers Dement       Date:  2019-01       Impact factor: 16.655

7.  Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease.

Authors:  Daniele Tolomeo; Edoardo Micotti; Sonia Colombo Serra; Michael Chappell; Anniina Snellman; Gianluigi Forloni
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.